ABVC BioPharma Stock Forecast for 2023 - 2025 - 2030
Updated on 05/05/2024
ABVC BioPharma Fair Value Forecast for 2023 - 2025 - 2030
ABVC BioPharma's Price has grown in the last year, jumping from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
ABVC BioPharma Revenue Forecast for 2023 - 2025 - 2030
ABVC BioPharma's Revenue has grown in the last two years, jumping from $480.00k to $970.00k – an increase of 102.08%. In the following year, 0 experts forecast ABVC BioPharma's Revenue will decrease by 30.82%, to $671.08k. In 2030, professionals predict that ABVC BioPharma's Revenue will decrease by 25.94%, to $718.37k.
.jpg)
ABVC BioPharma EBITDA Forecast for 2023 - 2025 - 2030
ABVC BioPharma's EBITDA has increased by 78.16% In the last two years, going from $-8.47M to $-15.09M. According to 0 analysts, ABVC BioPharma's EBITDA will fall by 24.20% in the next year, reaching $-11.44M. Professionals believe that By 2030, ABVC BioPharma's EBITDA will fall to $-11.92M – a 20.99% decrease from its current value.
ABVC BioPharma EBIT Forecast for 2023 - 2025 - 2030
In the last two years, ABVC BioPharma's EBIT has grown, increasing from $-8.51M to $-15.11M – a growth of 77.56%. In the following year, 0 experts forecast that ABVC BioPharma's EBIT will decrease by 24.11%, to $-11.47M. In 2030, professionals predict that ABVC BioPharma's EBIT will decrease by 20.93%, to $-11.95M.
ABVC BioPharma EPS Price Prediction Forecast for 2023 - 2025 - 2030
ABVC BioPharma's EPS has grown in the last year, jumping from $-4.49 to $0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
.jpg)